![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Obstructive Lung Diseases |
|
Free Subscription
3 Allergy |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Obstructive Lung Diseases is free of charge.
Is Asthma Remission a New Achievable Goal? A Review of the Current Drug-Related
Evidence and Predictors.
Allergy. 2026 May 14. doi: 10.1111/all.70388.
PubMed
Abstract available
Metabolite-Based Endotypes of Asthma Reveal Distinct Clinical Characteristics and
Immune Cell Signatures.
Allergy. 2026 May 13. doi: 10.1111/all.70385.
PubMed
Abstract available
Moesin, a Cytoskeletal-Associated Protein, Outperforms Candidate Biomarkers in
Identifying Asthma Exacerbation.
Allergy. 2026 May 11. doi: 10.1111/all.70389.
PubMed
Examining Sleep Quality and Mortality Risks in COPD, Asthma, and Asthma-COPD
Overlap Patients.
Am J Med. 2026 May 11:S0002-9343(26)00378-5. doi: 10.1016/j.amjmed.2026.
PubMed
Abstract available
Pirfenidone for asthma? What to do when standard therapies fail.
Am J Respir Cell Mol Biol. 2026 May 11:aanag103. doi: 10.1093.
PubMed
From mild-to-moderate to severe asthma: Risk factors and patient profiles from
the NORDSTAR cohort.
Am J Respir Crit Care Med. 2026 May 14:aamag242. doi: 10.1093.
PubMed
Abstract available
Reply to Sharma and Sharma: Parsing the Drivers of Bronchiolar Mucus Plugs in
Severe Asthma.
Am J Respir Crit Care Med. 2026 May 13:aamag202. doi: 10.1093.
PubMed
Parsing the Drivers of Bronchiolar Mucus Plugs in Severe Asthma.
Am J Respir Crit Care Med. 2026 May 13:aamag201. doi: 10.1093.
PubMed
Motivational interviewing and air cleaners for smokers with COPD (MOVE): a
randomized, double-blind, placebo-controlled trial.
Am J Respir Crit Care Med. 2026;212:952-963.
PubMed
Abstract available
Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe
Atopic Dermatitis Regardless of Atopic Comorbidities.
Ann Allergy Asthma Immunol. 2025 Dec 21:S1081-1206(25)01389.
PubMed
Abstract available
Relative particle size and distribution of inhaled triple therapies.
Ann Allergy Asthma Immunol. 2026;136:545-549.
PubMed
Abstract available
Bucher indirect treatment comparison of phase 3 trials with dupilumab and
tezepelumab in chronic rhinosinusitis with nasal polyps.
Ann Allergy Asthma Immunol. 2026;136:589-595.
PubMed
Abstract available
What's new in the care of patients with asthma?
Ann Allergy Asthma Immunol. 2026;136:501.
PubMed
Utility of Exhaled Nitric Oxide as a Potential Biomarker in Non-Asthmatics with
Multiple Food Allergies.
Ann Allergy Asthma Immunol. 2026 May 11:S1081-1206(26)00196.
PubMed
Impact of Biologics Administered for Severe Asthma on T2-comorbidities: A
Narrative Review.
Arch Bronconeumol. 2026 Apr 24:S0300-2896(26)00150.
PubMed
Abstract available
The World's Burden of Chronic Respiratory Disease: An Epidemiological Review of
Asthma, COPD, Interstitial Lung Disease, and Smoking in the 21st Century.
Arch Bronconeumol. 2026 Apr 23:S0300-2896(26)00151.
PubMed
Abstract available
Multiomics Approach Identifies Novel Genetic Determinants and Therapeutic Targets
for Asthma.
Can Respir J. 2026;2026:e6447989.
PubMed
Abstract available
Accuracy and Clinical Reasoning in Asthma Care: Insights from 14 Large Language
Models.
Chest. 2026;169:1167-1168.
PubMed
When Routine Becomes Risk: Proton Pump Inhibitors in COPD and Asthma.
Chest. 2026;169:1157-1158.
PubMed
Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung
Diseases.
Chest. 2026;169:1218-1227.
PubMed
Abstract available
The Economic Value of Reducing Asthma Mortality in 64 Countries, 2000-2022, With
Projections up to 2040: A Global Modelling Study.
Clin Exp Allergy. 2026 May 12. doi: 10.1111/cea.70337.
PubMed
Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income
Countries.
Clin Exp Allergy. 2026 May 15. doi: 10.1111/cea.70329.
PubMed
Abstract available
Nasal nitric oxide combined with clinical features for preliminary screening of
primary ciliary dyskinesia in bronchiectasis.
Eur Respir J. 2026 May 14:2502796. doi: 10.1183/13993003.02796-2025.
PubMed
Abstract available
CXCL16 as a Potential Therapeutic Target to Limit the Activity of Asthmatic CD4
Memory T cells.
J Allergy Clin Immunol. 2026 May 13:S0091-6749(26)00340.
PubMed
Abstract available
Circulating IL-6 Associates with a Distinct Pediatric Asthma Subtype and Serves
as a Potential Key Predictor for Risk Stratification.
J Asthma. 2026 May 13:1-19. doi: 10.1080/02770903.2026.2666086.
PubMed
Abstract available
J Investig Allergol Clin Immunol
Eosinophilic Pleural Effusion Following Long-Term Asthma Remission Under
Dupilumab Therapy: A Search for Clues Using Cytokine Analyses.
J Investig Allergol Clin Immunol. 2026 May 13:0. doi: 10.18176/jiaci.1184.
PubMed
Early childhood asthma and adiposity until adolescence: A prospective birth
cohort study using body fat percentage.
Pediatr Allergy Immunol. 2026;37:e70360.
PubMed
Abstract available
Asthma and allergy prevalence among children at risk for developmental
coordination disorder.
Pediatr Allergy Immunol. 2026;37:e70370.
PubMed
MicroRNA clustering in pediatric asthma reveals differential corticosteroid
responsiveness.
Pediatr Allergy Immunol. 2026;37:e70374.
PubMed
Abstract available
Identification of a diagnostic metabolomic fingerprint in plasma for eosinophilic
granulomatosis with polyangiitis.
PLoS One. 2026;21:e0343182.
PubMed
Abstract available
Usefulness of lung sound data collection using Skeeper SM-300(R) device: A pilot
study.
PLoS One. 2026;21:e0348588.
PubMed
Abstract available
Cost-effectiveness analysis of mepolizumab among patients with severe asthma from
the Chinese societal perspective.
PLoS One. 2026;21:e0348955.
PubMed
Abstract available
Development of an asthma policy model for Canada: Lifetime Exposures and Asthma
outcomes Projection.
PLoS One. 2026;21:e0348878.
PubMed
Abstract available
Increased potential for atherogenic changes in asthma: evidence from
transcriptomic studies of arterial endothelial cells.
Respir Res. 2026 May 12. doi: 10.1186/s12931-026-03709.
PubMed
Abstract available
Aerosol deposition in the lung as a biomarker in asthma and chronic obstruction.
Respir Res. 2026 May 11. doi: 10.1186/s12931-026-03706.
PubMed
Abstract available
[Indications and modalities of non-standard inhaled treatments for respiratory
pathologies: A narrative review].
Rev Mal Respir. 2026;43:34-48.
PubMed
Abstract available
Measurement properties of the sit-to-stand test in community-dwelling people with
chronic obstructive pulmonary disease: a COSMIN systematic review.
Thorax. 2026;81:581-590.
PubMed
Abstract available
Disproportionate impairment in diffusing capacity predicts pulmonary hypertension
with an elevated pulmonary vascular resistance in COPD.
Thorax. 2025 Nov 27:thorax-2025-223921. doi: 10.1136/thorax-2025-223921.
PubMed
Abstract available
Disproportionate increase in COPD exacerbation risk for 3 months after
discontinuing LAMA or ICS: insights from the FLAME trial.
Thorax. 2026;81:533-540.
PubMed
Abstract available
Development and validation of PRECISE-X model: predicting first severe
exacerbation in COPD.
Thorax. 2026;81:541-547.
PubMed
Abstract available
Never say die: making a death from asthma a never event.
Thorax. 2026 May 8:thorax-2025-224234. doi: 10.1136/thorax-2025-224234.
PubMed
Thank you for your interest in scientific medicine.